James Henry Zukin

Nessuna posizione attualmente

Finance

Consumer Services

Health Technology

Profilo

James Henry Zukin is the founder of Houlihan Lokey, Inc. which was founded in 1972.
He held the title of Director & Senior Managing Director at the company.
Mr. Zukin also founded Houlihan Lokey Capital, Inc. Mr. Zukin's former job was as an Independent Director at Athenex, Inc. from 2017 to 2018.
Mr. Zukin received his undergraduate degree from the University of California, Berkeley and his MBA from Harvard Business School.

Precedenti posizioni note di James Henry Zukin

Società	Posizione	Fine
ATHENEXPAR	Direttore/Membro del Consiglio	01/07/2018
Houlihan Lokey Capital, Inc. Houlihan Lokey Capital, Inc. Investment Banks/BrokersFinance Houlihan Lokey Capital, Inc. is a registered broker/dealer headquartered in Los Angeles, California. The firm was founded in 1996 and they are a subsidiary of Houlihan Lokey, Inc. (NYSE: HLI). Houlihan Lokey Capital provides an array of trading and execution services for their clients. They also have the ability to serve as underwriter or bookrunner with respect to traditional debt and equity offerings, including leveraged loans and public offerings of debt, equity-linked, and equity securities.	Fondatore	01/04/2014
HOULIHAN LOKEY, INC.	Fondatore	-

Vedi nel dettaglio l'esperienza di James Henry Zukin

Formazione di James Henry Zukin

University of California, Berkeley	Undergraduate Degree
Harvard Business School	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di James Henry Zukin

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
HOULIHAN LOKEY, INC.	Finance

Aziende private	2
Houlihan Lokey Capital, Inc. Houlihan Lokey Capital, Inc. Investment Banks/BrokersFinance Houlihan Lokey Capital, Inc. is a registered broker/dealer headquartered in Los Angeles, California. The firm was founded in 1996 and they are a subsidiary of Houlihan Lokey, Inc. (NYSE: HLI). Houlihan Lokey Capital provides an array of trading and execution services for their clients. They also have the ability to serve as underwriter or bookrunner with respect to traditional debt and equity offerings, including leveraged loans and public offerings of debt, equity-linked, and equity securities.	Finance
Athenex, Inc. Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY.	Health Technology